Most recent by Rachit Vakil, MD, MPH
SPONSORED CONTENT
December 16, 2019
5 min read
Save
Icosapent ethyl may act on plaque
A potential target for improving residual lipid-related risk for atherosclerotic CVD is reduction in triglyceride levels. Studies have shown eicosapentaenoic acid is effective in lowering triglyceride levels and reducing the risk for ischemic events in patients with elevated triglyceride levels already taking statin therapy.